Form EFFECT Theriva Biologics, Inc.
- Wall Street ends down after stunning jobs growth raises Fed questions
- Elon Musk wins 'funding secured' trial
- U.S. nonfarm payroll growth blows past forecasts in January, up 517k
- Analysts defend Apple (AAPL) as earnings miss drags shares lower
- Amazon (AMZN) drops after earnings, analysts worried about AWS uncertainty
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Notice of Effectiveness|
|Effectiveness Date:||December 8, 2022|
|Submission Type:||POS AM|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia
- Northwest Arkansas' First Robotic Total Knee Arthroplasty in an ASC Performed by C. Kris Hanby, M.D., of Ozark Orthopaedics
- Cohen Veterans Network Welcomes First Lady Jill Biden at the Cohen Clinic at VVSD in Oceanside, CA
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!